Package 72162-1527-5

Brand: bupropion hydrochloride (xl)

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 72162-1527-5
Digits Only 7216215275
Product NDC 72162-1527
Description

500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72162-1527-5)

Marketing

Marketing Status
Marketed Since 2024-01-23
Brand bupropion hydrochloride (xl)
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "5c6e1c88-d89c-4066-a5c0-df7e71f23223", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["a7553281-be90-47e3-8d2b-b027f6d18d3a"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72162-1527-3)", "package_ndc": "72162-1527-3", "marketing_start_date": "20240123"}, {"sample": false, "description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72162-1527-5)", "package_ndc": "72162-1527-5", "marketing_start_date": "20240123"}], "brand_name": "Bupropion Hydrochloride (XL)", "product_id": "72162-1527_5c6e1c88-d89c-4066-a5c0-df7e71f23223", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "72162-1527", "generic_name": "bupropion hydrochloride", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "(XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA207479", "marketing_category": "ANDA", "marketing_start_date": "20170412", "listing_expiration_date": "20261231"}